Your shopping cart is currently empty

Nor-MC3 is an ionizable cationic lipid utilized in creating liposomal lipid nanoparticles (LNPs) for delivering mRNA both in vitro and in vivo, derived from DLin-MC3-DMA. Liposomal LNPs with a molar ratio of 20:40:40:1.5 for nor-MC3:egg sphingomyelin:cholesterol:DMG-PEG(2000) show higher transfection efficiencies compared to those with a molar ratio of 50:10:38.5:1.5. Additionally, these LNPs exhibit increased accumulation in the spleen, pancreas, heart, kidney, muscle, and inguinal lymph nodes in mice.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Nor-MC3 is an ionizable cationic lipid utilized in creating liposomal lipid nanoparticles (LNPs) for delivering mRNA both in vitro and in vivo, derived from DLin-MC3-DMA. Liposomal LNPs with a molar ratio of 20:40:40:1.5 for nor-MC3:egg sphingomyelin:cholesterol:DMG-PEG(2000) show higher transfection efficiencies compared to those with a molar ratio of 50:10:38.5:1.5. Additionally, these LNPs exhibit increased accumulation in the spleen, pancreas, heart, kidney, muscle, and inguinal lymph nodes in mice. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.